Receptors providing targeted costimulation for adoptive cell therapy Grant US-11945876-B2 United States of America 02 Apr 2024
ANTI-CEACAM5 ANTIBODIES AND USES THEREOF Application EA-039377-B1 Eurasian Patent Organisation 20 Jan 2022
ANTI-CEACAM5 ANTIBODIES AND USES THEREOF Application EP-3594243-A1 European Patent Office 15 Jan 2020
Fusion protein to target and treat acute myeloid leukemia cells Grant US-10072093-B2 United States of America 11 Sep 2018
ANTI-CEACAM5 ANTIBODIES AND USES THEREOF Application EP-3199552-A1 European Patent Office 02 Aug 2017
BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2 Application WO-2015077891-A1 World Intellectual Property Organisation (WIPO) 04 Jun 2015
MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING EGFR AND/OR HER2 AND USES THEREOF Application WO-2015073721-A1 World Intellectual Property Organisation (WIPO) 21 May 2015
A NEW FUSION PROTEIN TO TARGET AND TREAT ACUTE MYLOID LEUKEMIA CELLS Application WO-2015001078-A1 World Intellectual Property Organisation (WIPO) 08 Jan 2015
BISPECIFIC HER2 AND HER3 ANTIGEN BINDING CONSTRUCTS Application WO-2014182970-A1 World Intellectual Property Organisation (WIPO) 13 Nov 2014
ANTI-CEACAM5 ANTIBODIES AND USES THEREOF Application WO-2014079886-A1 World Intellectual Property Organisation (WIPO) 30 May 2014